Biosciences announced the appointment of Sanjay Keswani, M.D., to the company’s executive management team as Chief Medical ...
Wells Fargo analyst Mohit Bansal maintained a Buy rating on Neurocrine (NBIX – Research Report) yesterday and set a price target of $180.00.
The direct successor to Nothing's best-selling phone to date loses out on the Pro's telephoto camera – but does try something ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback